adenoviral vector encoding Hyper-IL-6 (Hadassah University Hospital)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameadenoviral vector encoding Hyper-IL-6 (Hadassah University Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionIL-6 receptor agonistsInterleukin-6 modulators
TargetsIL-6 receptorInterleukin-6
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHadassah University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHadasit Medical Research Services & Development LtdHadassah University Hospital
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A